HIV -- KOL Insight and Consensus Outlook Modules

NEW YORK, March 4, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

HIV -- KOL Insight and Consensus Outlook Modules

http://www.reportlinker.com/p01937753/HIV----KOL-Insight-and-Consensus-Outlook-Modules.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

What do frontline clinicians really think about current HIV treatment pathways and what are the most pressing unmet needs that industry can respond to?

What's driving long term growth in HIV?

Poor adherence to prescribing programmes is a major issue in the management of HIV. Long acting injectable formulations and single dose combination therapies may help tackle this problem and in turn reduce transmission rates.Under diagnosis or late diagnosis often leads to patients presenting with advanced infection. This is a notoriously difficult area to influence, but could home self diagnosis be part of the answer? Only OraQuick's In-Home HIV test is approved in the US and there are none in Europe.As first-line anti-retroviral regimens have similar efficacy, the choice of therapies is determined by the type and likelihood of long term adverse effects such a renal function impairment and cardiovascular disease. New complete combination regimens may address some of these safety concerns, but products with reduced side-effect are both a development challenge and market opportunity.A complete ongoing analysis of current trends, forecasts and landscape modifiers

Harnessing the real world insights from leading US/European KOLs and research analysts, this study critically examines the HIV sector to expose the real potential. If you need instant access to an accurate, unbiased, qualitative review of the latest treatment trends along with a five-year quantitative HIV market forecast and insights as to the how HIV treatment will develop, look no further than FirstWord's Therapy Trends: HIV. This insightful FirstWord research is provided in two comprehensive modules:

The KOL Insight: HIV module provides a complete review underpinned by exclusive in-depth interviews with leading KOLs from the US and EuropeThe Consensus Outlook: HIV data analysis module provides annual historical and forecast product-level sales data based on leading equity analysts' projections. Key findings are given in a written analysis to support the visual data analyses provided in charts and tablesKOL Insight

KOL Insight Report

A qualitative analysis of the current and predicted treatment trends, clinical products and commercial drivers and resistors in the global HIV market, informed by in-depth expert views of the leading cliniciansCompare the market's key players, marketed products, late-stage pipeline drugs, current and future product positioning, in the context of HIV market trendsEvent-driven UpdatesBenefit from the latest KOL views about significant future event-driven changes in HIV treatment trendsConsensus Outlook

Consensus Report

An in-depth 5-year Consensus Outlook report of predicted quantitative changes in key HIV market forecast parameters drawn from 13 leading analyst and brokerage companiesChart HIV market size, product sales, market share by company, competitive status and detailed forecastsInteractive Analytics FileUse the interactive Excel market analytics module of detailed market and product sales data from 2007 to 2017 to drill down and assess key company, market and product trends

To order this report: HIV -- KOL Insight and Consensus Outlook Modules http://www.reportlinker.com/p01937753/HIV----KOL-Insight-and-Consensus-Outlook-Modules.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker